Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a new release of the page. The user-facing content remains unchanged.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a small update to the page's build. No substantive study details seem to be affected.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRecruitment status changed to 'No longer looking for participants'. The page adds new guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updates the Intervention/Treatment label, along with a revision to v3.6.0.SummaryDifference0.4%

- Check34 days agoChange DetectedThe page revision level was updated from v3.5.4 to v3.5.5, indicating a small internal update to the page metadata.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3. This reflects a technical site update and does not modify the study content or displayed results.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a minor administrative update to the study record.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.